Position Statement AME e Linee Guida

{seog:disable}

Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies. J Endocrinol Invest 2018, 41: 849–76.


Osteonecrosi delle ossa mascellari da bisfosfonati o denosumab: analisi del rischio e azioni cliniche. AME Raccomanda 1/2018


Italian Association of Clinical Endocrinologists (AME) and Italian Chapter of the American Association of Clinical Endocrinologists (AACE) Position Statement: Clinical Management of Vitamin D Deficiency in Adults. Nutrients 2018, 10, 546 (free full  text)


Assessment of Response to Treatment and Follow-Up in Gastroenteropancreatic Neuroendocrine Neoplasms. Endocr Metab Immune Disord Drug Targets 2018, DOI: 10.2174/1871530318666171213145803 (free full text).


Linee guida per il trattamento integrato del diabete mellito (traduzione del documento AACE e adattamento italiano). 2015-2017


AIT, ADI, AGICO, AME, FeSIN, FIMMG, SIE, SIEDP, SIGO, SINU, SINUT, SIP, SISDCA.  Uso di sale iodato in età adulta e in età pediatrica. 2017.


American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules – 2016 update. Endocr Pract 2016, 22 (suppl 1):  2-60 (free full text).


Italian Association of Clinical Endocrinologists Statement–Replacement Therapy for Primary Hypothyroidism: A Brief Guide for Clinical Practice. Endocr Pract 2016, 11: 1319–26.


Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis. J Endocrinol Invest 2016, DOI: 10.1007/s40618-016-0434-8.


Position statement AME: terapia sostitutiva dell’ipotiroidismo primitivo


Italian expert position sulla terapia medica nella sindrome di Cushing (forme ACTH-dipendenti e ACTH-indipendenti)


Position statement AME-AMD su Tireopatie e Diabete. Endocrine 2015, 49: 339-52.


Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms. J Endocrinol Invest 2014, 37: 875-909 (free full text).


Position statement su Iperparatiroidismo Primario. J Endocrinol Invest 2012, 35 (7 Suppl): 2-21.


Position statement su Incidentaloma surrenalico. Eur J Endocrinol 2011, 164: 851-70.


Position statement su Terapia del M. di Basedow (con AIT) 2011


Position statement su Ipertiroidismo e gravidanza (con AIT). J Endocrinol Invest 2011, 34: 225-31.


Position statement su Nodulo e tumore tiroideo in gravidanza (con AIT). J Endocrinol Invest 2010, 33: 579-86.


Position statement su Nodulo tiroideo (con AACE e ETA). J Endocrinol Invest 2010, 33 (5 Suppl): 1-50.


Position statement su Acromegalia. J Endocrinol Invest 2009, 32 (6 Suppl): 2-25.


Linee guida cliniche per la diagnosi e il trattamento della patologia nodulare tiroidea AME-AACE 2006.